AngioDynamics, Inc. (ANGO)
15.19
-0.28
(-1.81%)
USD |
NASDAQ |
Sep 04, 15:36
AngioDynamics Cash from Investing (Quarterly) : -1.27M for May 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.27M |
| February 28, 2026 | -1.507M |
| November 30, 2025 | -1.621M |
| August 31, 2025 | -1.551M |
| May 31, 2025 | -2.623M |
| February 28, 2025 | -3.189M |
| November 30, 2024 | -1.961M |
| August 31, 2024 | -2.405M |
| May 31, 2024 | -2.336M |
| February 29, 2024 | 29.40M |
| November 30, 2023 | -1.793M |
| August 31, 2023 | 98.44M |
| May 31, 2023 | -1.528M |
| February 28, 2023 | -2.146M |
| November 30, 2022 | -2.496M |
| August 31, 2022 | -3.576M |
| May 31, 2022 | -3.773M |
| February 28, 2022 | -2.593M |
| November 30, 2021 | -3.849M |
| August 31, 2021 | -9.092M |
| May 31, 2021 | -9.144M |
| February 28, 2021 | -1.382M |
| November 30, 2020 | -1.361M |
| August 31, 2020 | -1.824M |
| May 31, 2020 | -1.479M |
| Date | Value |
|---|---|
| February 29, 2020 | -11.74M |
| November 30, 2019 | -48.58M |
| August 31, 2019 | -1.541M |
| May 31, 2019 | 168.43M |
| February 28, 2019 | 0.463M |
| November 30, 2018 | -48.65M |
| August 31, 2018 | -37.68M |
| May 31, 2018 | -0.744M |
| February 28, 2018 | -1.69M |
| November 30, 2017 | -0.721M |
| August 31, 2017 | -0.501M |
| May 31, 2017 | -0.743M |
| February 28, 2017 | -0.412M |
| November 30, 2016 | -0.915M |
| August 31, 2016 | -0.481M |
| May 31, 2016 | -3.681M |
| February 29, 2016 | -2.745M |
| November 30, 2015 | -0.40M |
| August 31, 2015 | -0.743M |
| May 31, 2015 | -1.251M |
| February 28, 2015 | -4.269M |
| November 30, 2014 | -2.515M |
| August 31, 2014 | -5.258M |
| May 31, 2014 | -3.424M |
| February 28, 2014 | -1.817M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -1.956B |
| Penumbra, Inc. | -91.09M |
| Abbott Laboratories | -673.00M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 17.45M |
| Cash from Financing (Quarterly) | -0.108M |
| Free Cash Flow | -2.86M |
| Free Cash Flow Per Share (Quarterly) | 0.3881 |
| Free Cash Flow to Equity (Quarterly) | 16.62M |
| Free Cash Flow to Firm (Quarterly) | 16.29M |
| Free Cash Flow Yield | -0.45% |